PMID- 22805744 OWN - NLM STAT- MEDLINE DCOM- 20130305 LR - 20220129 IS - 1462-3994 (Electronic) IS - 1462-3994 (Linking) VI - 14 DP - 2012 Jul 6 TI - On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes. PG - e15 LID - 10.1017/erm.2012.9 [doi] AB - This review discusses mechanisms that link allelic variants of major histocompatibility complex (MHC) class II molecules (MHCII) to immune pathology. We focus on HLA (human leukocyte antigen)-DQ (DQ) alleles associated with celiac disease (CD) and type 1 diabetes (T1D) and the role of the murine DQ-like allele, H2-Ag7 (I-Ag7 or Ag7), in murine T1D. MHCII molecules bind peptides, and alleles vary in their peptide-binding specificity. Disease-associated alleles permit binding of disease-inducing peptides, such as gluten-derived, Glu-/Pro-rich gliadin peptides in CD and peptides from islet autoantigens, including insulin, in T1D. In addition, the CD-associated DQ2.5 and DQ8 alleles are unusual in their interactions with factors that regulate their peptide loading, invariant chain (Ii) and HLA-DM (DM). The same alleles, as well as other T1D DQ risk alleles (and Ag7), share nonpolar residues in place of Asp at beta57 and prefer peptides that place acidic side chains in a pocket in the MHCII groove (P9). Antigen-presenting cells from T1D-susceptible mice and humans retain CLIP because of poor DM editing, although underlying mechanisms differ between species. We propose that these effects on peptide presentation make key contributions to CD and T1D pathogenesis. FAU - Busch, Robert AU - Busch R AD - Department of Medicine, University of Cambridge, Cambridge, UK. rb468@medschl.cam.ac.uk FAU - De Riva, Alessandra AU - De Riva A FAU - Hadjinicolaou, Andreas V AU - Hadjinicolaou AV FAU - Jiang, Wei AU - Jiang W FAU - Hou, Tieying AU - Hou T FAU - Mellins, Elizabeth D AU - Mellins ED LA - eng GR - F32 AI089080/AI/NIAID NIH HHS/United States GR - R21 DK079163/DK/NIDDK NIH HHS/United States GR - R01 AR061297/AR/NIAMS NIH HHS/United States GR - AI095813/AI/NIAID NIH HHS/United States GR - UL1 RR025744/RR/NCRR NIH HHS/United States GR - UL1 TR001085/TR/NCATS NIH HHS/United States GR - AR061297/AR/NIAMS NIH HHS/United States GR - 18543/ARC_/Arthritis Research UK/United Kingdom GR - R21 AI095813/AI/NIAID NIH HHS/United States GR - AI089080/AI/NIAID NIH HHS/United States GR - 18543/VAC_/Versus Arthritis/United Kingdom PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20120706 PL - England TA - Expert Rev Mol Med JT - Expert reviews in molecular medicine JID - 100939725 RN - 0 (H-2 Antigens) RN - 0 (H-2A antigen) RN - 0 (HLA-DQ Antigens) RN - 0 (Peptides) SB - IM MH - Alleles MH - Animals MH - Celiac Disease/*genetics/immunology MH - Diabetes Mellitus, Type 1/*genetics/immunology MH - Genetic Variation/genetics MH - H-2 Antigens/*genetics/immunology MH - HLA-DQ Antigens/*genetics/immunology MH - Humans MH - Peptides/*genetics/immunology PMC - PMC4157902 MID - NIHMS622870 EDAT- 2012/07/19 06:00 MHDA- 2013/03/06 06:00 PMCR- 2014/09/08 CRDT- 2012/07/19 06:00 PHST- 2012/07/19 06:00 [entrez] PHST- 2012/07/19 06:00 [pubmed] PHST- 2013/03/06 06:00 [medline] PHST- 2014/09/08 00:00 [pmc-release] AID - S1462399412000099 [pii] AID - 10.1017/erm.2012.9 [doi] PST - epublish SO - Expert Rev Mol Med. 2012 Jul 6;14:e15. doi: 10.1017/erm.2012.9.